Alex D'souzaManaging Editoreditor@healthcaretechoutlook.comThe European genetic diagnostics market is undergoing a significant transformation, with technological advancements significantly expanding the scope of gene testing and therapy. Heightened consumer awareness and demand for early detection and prevention of inherent diseases are significant factors driving development. A notable example is the growing use of prenatal and newborn genetic diagnostics by the medical community to decrease the mortality rate caused by genetic disorders. Government initiatives promoting the adoption of genetic diagnostics in routine health check-ups have increased public access to affordable direct-to-consumer genetic testing (DTC-GT) kits. Simultaneously, private investments in research and development activities spurred innovations like CRISPR genome editing. Additional funding also empowers researchers to deepen their grasp of complex disorders, including various cancers and other chronic illnesses. These breakthroughs play a pivotal role in enabling precision medicine and personalised healthcare. The sector's development also holds substantial benefits for the growing elderly population, which Eurostat predicts that the EU-27 will be home to half a million centenarians by 2050. In this latest edition of Healthcare Tech Outlook, we feature genetic diagnostics solutions providers in Europe that continuously innovate and offer solutions that reshape the industry landscape in the region. It highlights GHG Genetics, a molecular genetics pioneer offering comprehensive genetic testing and counselling services. The firm leverages cutting-edge technologies and the expertise of its professional staff to deliver results that help individuals make informed decisions about their health. The magazine also highlights the valuable opinions of Matjaz Tavca, Project Manager at University Medical Centre Ljubljana, and Deb Lacava, Director Of Laboratory Services at University Medical Center of Southern Nevada (UMC), United States of America.We believe the insights these accomplished professionals share will empower you to make informed decisions for your business.Let us know your thoughts. Unveiling the Odyssey of the European Genetic Diagnostics MarketEditorialManaging EditorAlex D'souzaEditorial StaffAaron PaulJoe PhillipJames SmithMark Robert Wilson BrunoVega StanleyDavis MillsDebbie WillisVisualizerUTLOOKHealthcare Tech Copyright © 2023 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEmail:sales@healthcaretechoutlook.comeditor@healthcaretechoutlook.commarketing@healthcaretechoutlook.comImmanuelChris LynnNOVEMBER - 29 - 2023, volume 09 - Issue 19 Published by ValleyMedia, Inc. (ISSN 2691 - 3933)To subscribe to HealthcareTech OutlookVisit www.healthcaretechoutlook.com UTLOOKHealthcare Tech
< Page 5 | Page 7 >